Vaccines Clinical Trials

A listing of Vaccines medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 152 clinical trials
Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

that is not inferior to that observed in young women 16 to 26 years of age who receive the standard 3-dose regimen of 9-valent human papillomavirus (9vHPV) vaccine at 0, 2, and 6 months (i.e., the

  • 0 views
  • 16 Sep, 2021
  • 28 locations
A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas

This clinical study will evaluate the safety, tolerability and reactogenicity of 2 dose levels of mRNA 1893 Zika vaccine in comparison to a placebo control in healthy participants who are

  • 2 views
  • 23 Sep, 2021
  • 9 locations
Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

responses to SARS-CoV-2 mRNA vaccine and the risk of virologically-confirmed COVID-19-like illness and/or serologically-confirmed SARS-CoV-2 infection.

  • 0 views
  • 24 Sep, 2021
  • 21 locations
LAMP Detection of Malaria in PREGnancy (LAMPREG) Trial

Objective: The aim of this study is to evaluate the impact of enhanced malaria cases detection using molecular testing (LAMP) on maternal and infant morbidity and mortality in a prospective study design. A pragmatic randomized control diagnostic trial will be conducted from October 2020 until March 1 2022 in pregnant …

artemisinin
anemia
combination therapy
  • 3 views
  • 23 Sep, 2021
  • 3 locations
B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

The purpose of this study is to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations living with HIV: prior HBV vaccine recipients who are deemed non-responders

HIV Vaccine
vaccination
engerix-b
  • 0 views
  • 22 Sep, 2021
  • 38 locations
Safety Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 50 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI)

Safety, immunogenicity and efficacy of GSK S. aureus candidate vaccine (GSK3878858A) when administered to healthy adults (dose-escalation) and to adults 18 to 50 years of age with a recent S

abscess
cellulitis
drainage
bilateral ovariectomy
hysterectomy
  • 7 views
  • 21 Sep, 2021
  • 15 locations
Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira Democratic Republic of Congo

The aim of the study is to evaluate the impact of a large-scale urban water supply improvement intervention on cholera and other diarrhoeal diseases. The study uses a step wedge cluster randomised controlled trial (SWcRCT) to measure the effect of the intervention on cholera centre admission rates and confirmed cholera …

cholera vaccine
cholera
diarrhoeal disease
  • 0 views
  • 18 Sep, 2021
  • 3 locations
Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care

To determine the efficacy of an algorithm designed to recommend smoking cessation-related pharmacotherapy options to the primary care providers of smokers living with HIV/AIDS.

varenicline
bupropion
nicotine patch
HIV Vaccine
nicotine replacement
  • 0 views
  • 12 Sep, 2021
  • 1 location
PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)

Open-label, multicenter, dose titration and four-arm expansion trial to evaluate the safety, tolerability, immunogenicity, and preliminary efficacy of W_pro1 cancer vaccine (W_pro1) monotherapy

serum testosterone
prostatectomy
adenocarcinoma
cabazitaxel
docetaxel
  • 58 views
  • 22 Sep, 2021
  • 30 locations
UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma

UV1 is a therapeutic cancer vaccine that has been explored in prostate, lung cancer, in combination with ipilimumab in malignant melanoma and in combination with pembrolizumab in metastatic

immunologic adjuvant
vaccination
nivolumab
neutrophil count
pembrolizumab
  • 0 views
  • 18 Sep, 2021
  • 40 locations